DK0892852T3 - Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering - Google Patents

Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering

Info

Publication number
DK0892852T3
DK0892852T3 DK97919307T DK97919307T DK0892852T3 DK 0892852 T3 DK0892852 T3 DK 0892852T3 DK 97919307 T DK97919307 T DK 97919307T DK 97919307 T DK97919307 T DK 97919307T DK 0892852 T3 DK0892852 T3 DK 0892852T3
Authority
DK
Denmark
Prior art keywords
pro
cells expressing
encapsulated cells
drug activation
cytochrome
Prior art date
Application number
DK97919307T
Other languages
English (en)
Inventor
Walter H Guenzburg
Peter Karle
Robert Michael Saller
Original Assignee
Bavarian Nordic Res Inst As
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0892852(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic Res Inst As, Gsf Forschungszentrum Umwelt filed Critical Bavarian Nordic Res Inst As
Application granted granted Critical
Publication of DK0892852T3 publication Critical patent/DK0892852T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C12N9/0079—Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK97919307T 1996-03-27 1997-03-27 Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering DK0892852T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK35296 1996-03-27
EP97919307A EP0892852B1 (en) 1996-03-27 1997-03-27 Encapsulated cells expressing cytochrome p450 for prodrug activation

Publications (1)

Publication Number Publication Date
DK0892852T3 true DK0892852T3 (da) 2006-03-06

Family

ID=8092560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97919307T DK0892852T3 (da) 1996-03-27 1997-03-27 Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering

Country Status (19)

Country Link
US (1) US6893634B1 (da)
EP (1) EP0892852B1 (da)
JP (1) JP4229982B2 (da)
AT (1) ATE309383T1 (da)
AU (1) AU713382B2 (da)
CA (1) CA2250173A1 (da)
CZ (1) CZ288074B6 (da)
DE (1) DE69730595D1 (da)
DK (1) DK0892852T3 (da)
ES (1) ES2253775T3 (da)
HU (1) HU221349B1 (da)
IL (1) IL125795A0 (da)
NO (1) NO325392B1 (da)
NZ (1) NZ331765A (da)
PL (1) PL188323B1 (da)
RU (2) RU2185821C2 (da)
SI (1) SI0892852T1 (da)
SK (1) SK282744B6 (da)
WO (1) WO1997035994A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
SI0892852T1 (sl) 1996-03-27 2006-04-30 Bavarian Nordic As Inkapsulirane celice, ki eksprimirajo citokrom P450 za aktiviranje predzdravila
AU6328099A (en) * 1998-09-21 2000-04-10 Transgene S.A. Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
US7091040B1 (en) * 1999-01-04 2006-08-15 Innovata Plc P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT)
GB9900009D0 (en) * 1999-01-04 1999-02-24 Ml Lab Plc Gene therapy
GB0010105D0 (en) * 2000-04-26 2000-06-14 Ml Lab Plc Cell ablation
WO2003025191A2 (en) * 2001-09-21 2003-03-27 Oxford Biomedica (Uk) Limited Pseudotyped retroviral vector system
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
MX377487B (es) 2015-05-29 2025-03-04 Univ Mexico Nac Autonoma Nanoparticulas biocataliticas cyp-p22 con actividad citocromo p450 para la activacion de profarmacos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
JPH02504344A (ja) 1988-05-17 1990-12-13 スローン‐ケツテリング・インステイテユート・フオー・キヤンサー・リサーチ レトロウイルスベクター
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
RU2039593C1 (ru) * 1993-06-22 1995-07-20 Ф.А. Чернышкова Катализатор для получения фенола и ацетона
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
JP4037446B2 (ja) 1994-09-02 2008-01-23 ゲーエスエフ − フォルシュンクスツェントルム・フューア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 非自己不活化性の発現標的化レトロウイルスベクタ
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
JPH11511979A (ja) * 1995-09-06 1999-10-19 ババリアン・ノルディック・リサーチ・インスティテュート・アクティーゼルスカブ ヒト乳癌細胞を含むヒト乳腺細胞を標的として、連結された異種性遺伝子を発現させるためのｗａｐまたはｍｍｔｖ制御配列の使用
SI0892852T1 (sl) 1996-03-27 2006-04-30 Bavarian Nordic As Inkapsulirane celice, ki eksprimirajo citokrom P450 za aktiviranje predzdravila

Also Published As

Publication number Publication date
WO1997035994A3 (en) 1997-11-20
HU221349B1 (en) 2002-09-28
US6893634B1 (en) 2005-05-17
CA2250173A1 (en) 1997-10-02
NO984540D0 (no) 1998-09-28
EP0892852B1 (en) 2005-11-09
NO325392B1 (no) 2008-04-21
JP2000509249A (ja) 2000-07-25
JP4229982B2 (ja) 2009-02-25
SK132398A3 (en) 1999-04-13
WO1997035994A2 (en) 1997-10-02
HUP9904116A3 (en) 2001-01-29
AU2382797A (en) 1997-10-17
RU2185821C2 (ru) 2002-07-27
PL329071A1 (en) 1999-03-15
NZ331765A (en) 2000-02-28
SI0892852T1 (sl) 2006-04-30
DE69730595D1 (de) 2004-10-14
NO984540L (no) 1998-09-28
RU2223788C2 (ru) 2004-02-20
CZ288074B6 (cs) 2001-04-11
AU713382B2 (en) 1999-12-02
HUP9904116A2 (hu) 2000-04-28
ES2253775T3 (es) 2006-06-01
SK282744B6 (sk) 2002-12-03
ATE309383T1 (de) 2005-11-15
PL188323B1 (pl) 2005-01-31
IL125795A0 (en) 1999-04-11
EP0892852A2 (en) 1999-01-27
CZ305098A3 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
PY950041A (es) Compuesto de 1- fenil 3-dimetilamino- propano a procedimientos para su preparacion y a la aplicacion de estas sustancias en farmacologia
SE9801336D0 (sv) Enterala fluoxetin-piller
DK0892852T3 (da) Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering
AU1534699A (en) Osmotic dosage form comprising first and second coats
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
DE69808130D1 (de) Adamantan-derivate
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
AR016827A1 (es) PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
SE9704546D0 (sv) Novel compounds
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
NO973850D0 (no) Fenylsubstituerte alkenylkarboksylsyreguanidider; fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostika såvel som medikamenter inneholdende dem
DE3764595D1 (de) Herstellung einer gliedprothese und materialien, die dazu benoetigt werden.
AU6211501A (en) Dental care agents provided in the form of single-portion capsules
WO1991015512A3 (en) Hiv envelope polypeptides
DE60043442D1 (de) Ner aktiven phase und einer inaktiven phase
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
DK1119363T3 (da) Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel
NO985571L (no) Legemiddel for autoimmunsykdommer
GT199900062A (es) Preparados efervescentes.
NO992999L (no) Farmasöytisk blanding for oral administrering
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
NO890096D0 (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.